EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
作者： Heather Scharpenseel , Annkathrin Hanssen , Sonja Loges , Malte Mohme , Christian Bernreuther
DOI: 10.1038/S41598-019-43678-6
关键词:
摘要: … Based on these results, the here described magnetic CTC enrichment technique was established using biotinylated antibodies to isolate CTCs that express these therapeutically …
nature.com
harvard.edu
fis-uke.de参考文章(34)
Debby D. Wang, Lichun Ma, Maria P. Wong, Victor H. F. Lee, Hong Yan, Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0128360
K Yonesaka, K Hirotani, H Kawakami, M Takeda, H Kaneda, K Sakai, I Okamoto, K Nishio, PA Jänne, K Nakagawa, None, Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib Oncogene. ,vol. 35, pp. 878- 886 ,(2016) , 10.1038/ONC.2015.142
Adi F. Gazdar, Shinichi Toyooka, Kazunori Tsukuda, Mitsune Tanimoto, Masahiro Tabata, Kouichi Ichimura, Masaaki Yano, Toshihide Tsuda, Hisayuki Shigematsu, Hiroshi Date, Kunitoshi Tomii, Nobuyoshi Shimizu, Hiroshi Ueoka, Motoi Aoe, Masaki Tokumo, Katsuyuki Kiura, The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers Clinical Cancer Research. ,vol. 11, pp. 1167- 1173 ,(2005)
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Luis Paz-Ares, Denis Soulières, Ivan Melezínek, Joachim Moecks, Lorenz Keil, Tony Mok, Rafael Rosell, Barbara Klughammer, Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis Journal of Cellular and Molecular Medicine. ,vol. 14, pp. 51- 69 ,(2010) , 10.1111/J.1582-4934.2009.00991.X
Zhao Chen, Christine M. Fillmore, Peter S. Hammerman, Carla F. Kim, Kwok-Kin Wong, Non-small-cell lung cancers: a heterogeneous set of diseases Nature Reviews Cancer. ,vol. 14, pp. 535- 546 ,(2014) , 10.1038/NRC3775
Sabine Riethdorf, Herbert Fritsche, Volkmar Müller, Thomas Rau, Christian Schindlbeck, Brigitte Rack, Wolfgang Janni, Cornelia Coith, Katrin Beck, Fritz Jänicke, Summer Jackson, Terrie Gornet, Massimo Cristofanilli, Klaus Pantel, Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System Clinical Cancer Research. ,vol. 13, pp. 920- 928 ,(2007) , 10.1158/1078-0432.CCR-06-1695
Nicola Aceto, Aditya Bardia, David T. Miyamoto, Maria C. Donaldson, Ben S. Wittner, Joel A. Spencer, Min Yu, Adam Pely, Amanda Engstrom, Huili Zhu, Brian W. Brannigan, Ravi Kapur, Shannon L. Stott, Toshi Shioda, Sridhar Ramaswamy, David T. Ting, Charles P. Lin, Mehmet Toner, Daniel A. Haber, Shyamala Maheswaran, Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis Cell. ,vol. 158, pp. 1110- 1122 ,(2014) , 10.1016/J.CELL.2014.07.013
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, T. Kosaka, A. J. Holmes, A. M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B. E. Johnson, L. C. Cantley, P. A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science. ,vol. 316, pp. 1039- 1043 ,(2007) , 10.1126/SCIENCE.1141478
Anna Sophie Berghoff, Manuel Magerle, Ayseguel Ilhan-Mutlu, Carina Dinhof, Georg Widhalm, Karin Dieckman, Christine Marosi, Adelheid Wöhrer, Monika Hackl, Sabine Zöchbauer-Müller, Matthias Preusser, Peter Birner, Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients. Apmis. ,vol. 121, pp. 1144- 1152 ,(2013) , 10.1111/APM.12063